Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Semin Nephrol. 2009;29:227–38.
Kugler JP, Hustead T. Hyponatremia and hypernatremia in the elderly. Am Fam Physician. 2000;61:3623–30.
Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003;37:1694–702.
Hoorn EJ, Zietse R. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis. 2013;62:139–49.
Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. Q J Med. 2008;101:583–8.
Gross P. Treatment of hyponatremia. Intern Med. 2008;47:885–91.
Rapoport M, Mamdani M, Shulman KI, Herrmann N, Rochon PA. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry. 2005;20:749–53.
Summary Safety Review - Atypical Antipsychotics - Liver failure. Health Canada. 2015. http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/antipsycho-eng.php#fnb1. Accessed 26 Sept 2015.
Whitten JR, Ruehter VL. Risperidone and hyponatremia: a case report. Ann Clin Psychiatry. 1997;9:181–3.
Atalay A, Turhan N, Aki OE. A challenging case of syndrome of inappropriate secretion of antidiuretic hormone in an elderly patient secondary to quetiapine. South Med J. 2007;100:832–3.
Kahn D, Leung M, Kerri K, Quanbeck C, Su A. Two patients with recurring syndrome of inappropriate secretion of antidiuretic hormone on multiple atypical antipsychotics. J Clin Psychopharmacol. 2009;29:182–99.
Collins A, Anderson J. SIADH induced by two atypical antipsychotics. Int J Geriatr Psychiatry. 2000;15:282–5.
Meulendijks D, Mannesse CK, Jansen PA, Van Marum RJ, Egberts TCG. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf. 2010;33:101–14.
Dudeja SJ, McCormick M, Dudeja RK. Olanzapine induced hyponatraemia. Ulster Med J. 2010;79:104–5.
Bhuvaneswar CG, Baldessarini RJ, Harsh VL, Alpert JE. Adverse endocrine and metabolic effects of psychotropic drugs. CNS Drugs. 2009;23:1003–22.
Crossley NA, Constante M, McGuire P, Power P. Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry. 2010;196:434–9.
Mannesse CK, van Puijenbroek EP, Jansen P a F, van Marum RJ, Souverein PC, Egberts TCG. Hyponatraemia as an adverse drug reaction of antipsychotic drugs. Drug Saf. 2010;33:569–78.
Van Der Heijden PGM, Van Puijenbroek EP, Van Buuren S, Van Der Hofstede JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med. 2002;21:2027–44.
Population by sex and age group, by province and territory. Statistics Canada. 2014. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo31a-eng.htm. Accessed 20 Aug 2015.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–9.
Levy AR, O’Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67–71.
Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, Garg AX. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. 2013;310:2544–53.
Weir MA, Fleet JL, Vinden C, Shariff SZ, Liu K, Song H, Jain AK, Gandhi S, Clark WF, Garg AX. Hyponatremia and sodium picosulfate bowel preparations in older adults. Am J Gastroenterol. 2014;109:686–94.
Hwang YJ, Dixon SN, Reiss JP, Wald R, Parikh CR, Gandhi S, Shariff SZ, Pannu N, Nash DM, Rehman F, Garg AX. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med. 2014;161:242–8.
Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med. 2013;158:869–76.
Weir MA, Juurlink DN, Gomes T, Mamdani M, Hackam DG, Jain AK, Garg AX. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. Clin J Am Soc Nephrol. 2010;5:1544–51.
Austin PC. An Introduction to propensity score methods for reducing the effects of confounding in observational studies. 2011;46(3):399-424.
Gandhi S, Shariff SZ, Fleet JL, Weir MA, Jain AK, Garg AX. Validity of the International Classification of Diseases 10th revision code for hospitalisation with hyponatremia in elderly patients. BMJ Open. 2012;2:1–11.
Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228–34.
Fleet JL, Dixon SN, Shariff SZ, Quinn RR, Nash DM, Harel Z, Garg AX. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14:81.
Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002;144:290–6.
UpToDate Online V. 23.7. Risperidone: Drug information. 2015. http://www.uptodate.com/contents/risperidone-drug-information?source=see_link. Accessed 20 Oct 2015.
UpToDate Online V. 23.7. Olanzapine: Drug information. 2015. http://www.uptodate.com/contents/olanzapine-drug-information?source=see_link. Accessed 20 Oct 2015.
UpToDate Online V. 23.7. Quetiapine: Drug information. 2015. http://www.uptodate.com/contents/quetiapine-drug-information?source=see_link. Accessed 20 Oct 2015.
Risperdal [product monograph]: Compendium of Pharmaceuticals and Specialties. Ottawa, Canada: Canadian Pharmacists Association; 2008.
Zyprexa [product monograph]: Compendium of Pharmaceuticals and Specialties. Ottawa, Canada: Canadian Pharmacists Association; 2008.
Seroquel [product monograph]: Compendium of Pharmaceuticals and Specialties. Ottawa, Canada: Canadian Pharmacists Association; 2008.
Gandhi S, Shariff SZ, Beyea MM, Weir MA, Hands T, Kearns G, Garg AX. Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes. BMJ Open. 2013;3:1–6.
Bersani G, Pesaresi L, Orlandi V, Gherardelli S, Pancheri P. Atypical antipsychotics and polydipsia: a cause or treatment. Hum Psychopharmacol. 2007;22:103–7.
Maglione M, Bagley S, Suttorp M, Ewing B, Wang Z, Timmer M, Sultzer D. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. J Am Med Assoc. 2011;306:1359–69.
Gareri P, Segura-garcía C, Laura VG, Bruni A, Ciambrone P, Cerminara G. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363-73.
Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol. 2003;23:389–99.
Valenstein M, Blow FC, Copeland L a, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004;30:255–64.
Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119:1–8.